Search

everythinglearnresearchcommunity

for

Search:↓

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Laser-Assisted Exosome Delivery showed early skin improvement without side effects, but more research is needed.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

COVID-19 may worsen Parkinson's disease by affecting certain brain proteins.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Certain genes in fat tissue affect weight loss in women with PCOS.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Early treatment with corticosteroids and immunosuppressants is crucial for managing Vogt-Koyanagi-Harada disease.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Exclamation mark hairs help distinguish syphilitic alopecia from alopecia areata.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

New regenerative treatments show promise in improving hair growth for androgenetic alopecia.

Personalized skin rejuvenation using genomics shows promise but needs more research.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

About one-third of Saudi women with female pattern hair loss also have thinning hair at the back of their head.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

New understanding and treatments for hair loss are improving, but more research is needed.

Platelet-rich plasma helps treat hair loss, and better screening improves transfusion safety.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.